Cynosure Cellulaze

Cellulite treatment · 1440nm subdermal laser for cellulite

Work at Cynosure? — one claim covers all 24 of your devices.
DiscontinuedBe the first to review

New Cynosure Cellulaze pricing is not published; used and refurbished systems trade around $15k–$40k. Cynosure Cellulaze holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.

What it's actually cleared for: Minimally invasive 1440nm side-firing laser for cellulite structure

Last verified: August 6, 2026 · How we verify

New: |Used: $15k–$40kmarket estimate, no email required

Key facts
ManufacturerCynosure
CompanyOwner: Hahn & Company (South Korean private equity) (private equity owned, since 2024) · Distribution: direct
CategoryBody Contouring
Technology1440nm subdermal laser for cellulite
FDA statusFDA Cleared
New price rangeNot published
Used price range$15k–$40k
ConsumablesNot published
Launch year2012
Last verifiedAugust 6, 2026
Save device

Overview

First FDA-cleared minimally invasive cellulite laser

FDA & regulatory status

Authorized via 510(k)

What it's actually cleared for:

Minimally invasive 1440nm side-firing laser for cellulite structure

510(k) numbers

K102541

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Recent industry events

How we source company data

Ownership and corporate changes at Cynosure that can affect warranty, service and parts availability.

  1. Jan 2024

    Cynosure and Lutronic merge under Hahn & Company

    Merger

    Cynosure and Lutronic announced their merger on January 19, 2024, closing later that year to form Cynosure Lutronic, Inc. under South Korean private equity firm Hahn & Company; terms undisclosed. This followed CD&R's 2019 purchase of Cynosure from Hologic for $205M and Hahn's 2023 acquisition of Lutronic.

    Source: PR Newswire (Jan 19, 2024); Hologic filings

Treatment economics

Economics data for this platform hasn't been published yet.

Chains using this device

No confirmed chain deployments recorded yet.

Owner reviews

Write a review

No verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.

Alternatives

BTL Aesthetics Cellutone

Cellulite treatment

BTL Aesthetics X-Wave

Cellulite treatment

Revelle Aesthetics Aveli

Cellulite treatment

DEKA/Cynosure TriActive

Cellulite treatment

History

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. August 5, 2026

    FDA status

    UnknownCleared

    Source: Automatic record update

  2. August 5, 2026

    FDA K-numbers

    K102541

    Source: Automatic record update

  3. August 5, 2026

    FDA indication

    Minimally invasive 1440nm side-firing laser for cellulite structure

    Source: Automatic record update

  4. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Get the full State of Aesthetic Devices 2026 report

The first full census of the US aesthetic device market — preview it free.

Get the report